Mediators of Inflammation · 2014 · 67 citations · 39 references
Veterinary MedicineImmunologyInfectious DiseasesImmunology Of Infectious DiseasesImmunopathologyInflammationChagas DiseaseHost-parasite Immune InteractionsImmunopathology Of Infectious DiseasesImmunopathology Of Parasitic DiseaseImmunoregulation In Parasitic InfectionT-cell Responses To ParasitesCardiac Conduction AbnormalitiesChagas CardiomyopathyChagas Heart DiseaseChronic Chagas DiseaseHeart Failure ProgressionTrypanosoma Cruzi InfectionTrypanosomatid-host InteractionsTumor Necrosis Factor Therapy
BACKGROUND: Chagas disease (CD) is characterized by parasite persistence and immunological unbalance favoring systemic inflammatory profile. Chronic chagasic cardiomyopathy, the main manifestation of CD, occurs in a TNF-enriched milieu and frequently progresses to heart failure. AIM OF THE STUDY: To challenge the hypothesis that TNF plays a key role in Trypanosoma cruzi-induced immune deregulation and cardiac abnormalities, we tested the effect of the anti-TNF antibody Infliximab in chronically T. cruzi-infected C57BL/6 mice, a model with immunological, electrical, and histopathological abnormalities resembling Chagas' heart disease. RESULTS: Infliximab therapy did not reactivate parasite but reshaped the immune response as reduced TNF mRNA expression in the cardiac tissue and plasma TNF and IFNγ levels; diminished the frequency of IL-17A(+) but increased IL-10(+) CD4(+) T-cells; reduced TNF(+) but augmented IL-10(+) Ly6C(+) and F4/80(+) cells. Further, anti-TNF therapy decreased cytotoxic activity but preserved IFNγ-producing VNHRFTLV-specific CD8(+) T-cells in spleen and reduced the number of perforin(+) cells infiltrating the myocardium. Importantly, Infliximab reduced the frequency of mice afflicted by arrhythmias and second degree atrioventricular blocks and decreased fibronectin deposition in the cardiac tissue. CONCLUSIONS: Our data support that TNF is a crucial player in the pathogenesis of Chagas' heart disease fueling immunological unbalance which contributes to cardiac abnormalities.
39
M. A. Kondo, K. Tajinda, C. Colantuoni et al. · 2012 · 660 citations
IL-17 Enhances Chemokine Gene Expression through mRNA Stabilization
Justin Hartupee, Caini Liu, Michael Novotny et al. · The Journal of Immunology · 2007 · 281 citations · Full text